Amiodarone and thyroid hormone metabolism.
作者信息
Wiersinga W M, Trip M D
出版信息
Postgrad Med J. 1986 Oct;62(732):909-14. doi: 10.1136/pgmj.62.732.909.
Abstract
摘要
相似文献
1
Amiodarone and thyroid hormone metabolism.胺碘酮与甲状腺激素代谢
Postgrad Med J. 1986 Oct;62(732):909-14. doi: 10.1136/pgmj.62.732.909.
2
[Thyroid function and amiodarone. Consequences on dysthyroidism testing].
Ann Cardiol Angeiol (Paris). 1985 Jan;34(1):5-10.
3
[Amiodarone and the thyroid].
Med Clin (Barc). 1985 Mar 16;84(10):397-9.
4
[Thyroid and treatment with amiodarone diagnosis, therapy and clinical management].[甲状腺与胺碘酮治疗：诊断、治疗及临床管理]
Wien Med Wochenschr. 2008;158(1-2):29-35. doi: 10.1007/s10354-007-0475-x.
5
[Amiodarone and thyroid function].
G Ital Cardiol. 1984 Dec;14(12):1069-76.
6
Amiodarone and the thyroid: pharmacological, toxic and therapeutic effects.
J Intern Med. 1993 Jun;233(6):435-43. doi: 10.1111/j.1365-2796.1993.tb00997.x.
7
Thyroid Disease and the Heart.甲状腺疾病与心脏
Curr Probl Cardiol. 2016 Feb;41(2):65-92. doi: 10.1016/j.cpcardiol.2015.04.002. Epub 2015 Apr 23.
8
[Thyroid pathology iatrogenically induced by iodinated products].[碘化产品医源性诱导的甲状腺病理变化]
Rev Med Brux. 1985 Jun;6(6):412-4.
9
Amiodarone-induced thyroid gland dysfunction.
Am J Cardiol. 1987 Apr 1;59(8):833-5. doi: 10.1016/0002-9149(87)91101-5.
10
Towards an animal model of amiodarone-induced thyroid dysfunction.迈向胺碘酮诱导的甲状腺功能障碍动物模型。
Eur J Endocrinol. 1997 Jul;137(1):15-7. doi: 10.1530/eje.0.1370015.
引用本文的文献
1
Novel Biomarkers Reveal Mismatch Between Tissue and Serum Thyroid Hormone Status in Amiodarone-Induced Hyperthyroidism.新型生物标志物揭示胺碘酮所致甲状腺功能亢进症中组织与血清甲状腺激素状态的不匹配。
J Clin Endocrinol Metab. 2025 Jan 21;110(2):374-386. doi: 10.1210/clinem/dgae514.
2
Low dose amiodarone reduces tumor growth and angiogenesis.小剂量胺碘酮可抑制肿瘤生长和血管生成。
Sci Rep. 2020 Oct 22;10(1):18034. doi: 10.1038/s41598-020-75142-1.
3
2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction.2018年欧洲甲状腺协会（ETA）胺碘酮相关性甲状腺功能障碍管理指南。
Eur Thyroid J. 2018 Mar;7(2):55-66. doi: 10.1159/000486957. Epub 2018 Feb 14.
4
Management of amiodarone-related thyroid problems.胺碘酮相关甲状腺问题的管理。
Ther Adv Endocrinol Metab. 2011 Jun;2(3):115-26. doi: 10.1177/2042018811398516.
5
Total thyroidectomy for medically refractory amiodarone-induced thyrotoxicosis.因胺碘酮所致药物难治性甲状腺毒症而行甲状腺全切除术。
Proc (Bayl Univ Med Cent). 2008 Oct;21(4):382-5. doi: 10.1080/08998280.2008.11928432.
6
Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.脱碘酶调节甲状腺激素信号传导的细胞和分子基础。
Endocr Rev. 2008 Dec;29(7):898-938. doi: 10.1210/er.2008-0019. Epub 2008 Sep 24.
7
Trace amine-associated receptor 1 (TAAR1) is activated by amiodarone metabolites.痕量胺相关受体1（TAAR1）可被胺碘酮代谢产物激活。
Bioorg Med Chem Lett. 2008 Nov 15;18(22):5920-2. doi: 10.1016/j.bmcl.2008.08.013. Epub 2008 Aug 9.
8
Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy.胺碘酮与甲状腺：胺碘酮治疗所致甲状腺功能障碍管理实用指南
Heart. 1998 Feb;79(2):121-7. doi: 10.1136/hrt.79.2.121.
9
Amiodarone and thyroid autoimmunity in the United Kingdom.英国的胺碘酮与甲状腺自身免疫
BMJ. 1988 Jul 2;297(6640):33. doi: 10.1136/bmj.297.6640.33.
10
Brain abscess presenting as an intracranial gas shadow.表现为颅内气体影的脑脓肿。
Br Med J (Clin Res Ed). 1987 Feb 7;294(6568):365-6. doi: 10.1136/bmj.294.6568.365.
本文引用的文献
1
Thyroid function tests. II. Studies in patients with thyroid diseases.甲状腺功能测试。II. 甲状腺疾病患者的研究。
Neth J Med. 1980;23(5):200-9.
2
[Amiodarone and the thyroid gland].[胺碘酮与甲状腺]
Schweiz Med Wochenschr. 1981 Oct 24;111(43):1590-6.
3
Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration.
J Clin Endocrinol Metab. 1981 Nov;53(5):997-1001. doi: 10.1210/jcem-53-5-997.
4
Decreased transport of thyroxine (T4), 3,3',5-triiodothyronine (T3) and 3,3',5'-triiodothyronine (rT3) into rat hepatocytes in primary culture due to a decrease of cellular ATP content and various drugs.由于细胞ATP含量降低及多种药物的作用，原代培养的大鼠肝细胞对甲状腺素（T4）、3,3',5-三碘甲状腺原氨酸（T3）和3,3',5'-三碘甲状腺原氨酸（反T3）的转运减少。
FEBS Lett. 1982 Apr 19;140(2):229-33. doi: 10.1016/0014-5793(82)80900-9.
5
Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.胺碘酮治疗期间血清反三碘甲状腺原氨酸水平的药代动力学意义：一种监测慢性药物治疗的潜在方法。
Circulation. 1982 Jul;66(1):202-11. doi: 10.1161/01.cir.66.1.202.
6
Evidence for two tissue-specific pathways for in vivo thyroxine 5'-deiodination in the rat.大鼠体内甲状腺素5'-脱碘作用存在两条组织特异性途径的证据。
J Clin Invest. 1982 May;69(5):1176-84. doi: 10.1172/jci110554.
7
Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.胺碘酮治疗难治性快速性心律失常的临床药代动力学及疗效
Circulation. 1983 Jun;67(6):1347-55. doi: 10.1161/01.cir.67.6.1347.
8
[Diagnosis of hyper- and hypothyroidism in patients using amiodarone].[使用胺碘酮患者甲状腺功能亢进和减退的诊断]
Ned Tijdschr Geneeskd. 1983 Mar 12;127(11):456-61.
9
Are selective increases in serum thyroxine (T4) due to iodinated inhibitors of T4 monodeiodination indicative of hyperthyroidism?
J Clin Endocrinol Metab. 1982 Dec;55(6):1058-65. doi: 10.1210/jcem-55-6-1058.
10
Prednisone in amiodarone-induced thyrotoxicosis.泼尼松治疗胺碘酮所致甲状腺毒症
Br Med J (Clin Res Ed). 1982 Jun 19;284(6332):1835-6. doi: 10.1136/bmj.284.6332.1835-a.
Zotero 插件